Senior insider sale
Chief Discovery Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$135.1K
5K shares
What this filing means
KREITZER ANATOL plans to sell 5K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $135.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001193125-26-157260
Officer· Chief Discovery Officer
Since Feb 2026
5K
Shares to sell
$135.1K
Approx. market value
9.09K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock unit settlement
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
4/15/2026
9.09KTotal acquired9.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/15/2026 | Restricted stock unit settlement Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 9.09K | — |
| Total | 9.09K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
5K
Market value
$135.1K
4/15/2026
Total
Units
5K
Value
$135.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/15/2026 | 5K | $135.1K | Nasdaq | Planned |
| Total | 5K | $135.1K | ||